140 results
6-K
EX-99.2
AMYT
Amryt Pharma Plc
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
EXHIBIT 99.2
Amryt Receives Reimbursement Approval from the French Ministry of Social Affairs and Health for Myalepta® (metreleptin)
DUBLIN … that the French Ministry of Social Affairs and Health has approved Myalepta® (metreleptin) for reimbursement in France as an adjunct to diet as replacement
6-K
EX-99.1
AMYT
Amryt Pharma Plc
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
. Therefore, in planning the AGM, we have been mindful of the need to ensure a COVID-secure meeting with appropriate social distancing for any Shareholders who … in the political, social and regulatory framework in which Amryt operates or in economic, technological or consumer trends or conditions. Past performance
424B3
AMYT
Amryt Pharma Plc
31 Jan 22
Prospectus supplement
7:35am
ability to obtain financing, changes in the political, social and regulatory framework in which Amryt operates or in economic, technological or consumer … , the outcome of clinical trials, the actions of regulators and other factors such as Amryt's ability to obtain financing, changes in the political, social
424B3
AMYT
Amryt Pharma Plc
31 Jan 22
Prospectus supplement
7:33am
ability to obtain financing, changes in the political, social and regulatory framework in which Amryt operates or in economic, technological or consumer … , the outcome of clinical trials, the actions of regulators and other factors such as Amryt's ability to obtain financing, changes in the political, social
424B3
AMYT
Amryt Pharma Plc
31 Mar 22
Prospectus supplement
8:44am
trials, the actions of regulators and other factors such as Amryt's ability to obtain financing, changes in the political, social and regulatory … trials, the actions of regulators and other factors such as Amryt's ability to obtain financing, changes in the political, social and regulatory framework
424B3
5j7aprpo90 qp4jz
31 Mar 22
Prospectus supplement
8:44am
6-K
EX-99.1
yqdoso
28 Jun 21
Current report (foreign)
9:16am
6-K
EX-99.4
y5p9rk6 g6x78v1
12 Apr 23
Current report (foreign)
5:28pm
424B3
mds500
28 Jun 21
Prospectus supplement
9:17am
6-K
EX-99.6
j4ylgus5rl4xqml
3 Nov 22
Current report (foreign)
7:44am
424B3
s11iadsn4
23 Aug 21
Prospectus supplement
8:18am
424B3
fhe6887t zffdjg
23 Aug 21
Prospectus supplement
8:17am
6-K
EX-99.1
38ja0umw56qpb
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.3
zsss8trtizug2gnr4
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.1
luyshkuxtg7pv5fm94
1 Jun 22
Current report (foreign)
6:05am
424B3
v05qlhawezz c67f
28 Jun 21
Prospectus supplement
9:18am
6-K
EX-99.1
x6oyhdd73j1ae5y9hs
31 Mar 22
Results of General Meeting
8:41am
6-K
EX-99.4
jo4fe6 4twqdybeeb
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.3
vpo7d
29 Oct 21
Current report (foreign)
6:05am
6-K
EX-99.5
w2nnt0 9lyov8x
31 Jan 22
Current report (foreign)
7:32am